Reference price system initially applying to 4,557 drugs.

In the policy debate over the Reference Price System on Sept. 19 Mr. Han Oh-suk, the chief officer of the Survey and Research Institute of the Health Insurance Review Agency (HIRA) indicated under his presentation titled "The reference price system review: A foreign application case and how to apply it into Korea" that the system would be desirable to apply initially to the drug groups belongin...